XTSE
PYR
Market cap34mUSD
Jul 09, Last price
0.22CAD
1D
0.00%
1Q
-52.75%
Jan 2017
7.50%
IPO
-79.52%
Name
Pyrogenesis Canada Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Montréal-based PyroGenesis Canada Inc. is an international pioneer in the development, manufacturing, and commercialization of advanced plasma processes and systems. Their portfolio includes several proprietary technologies: DROSRITE efficiently recovers metal from dross in the aluminum and zinc industries without generating hazardous by-products. PUREVAP converts quartz into high-purity metallurgical and solar-grade silicon. The PUREVAP Nano Silicon Reactor further processes silicon into spherical powders and nanowires, essential components for lithium-ion battery technology. High-powered APT plasma torches serve as a clean alternative to traditional fossil fuel burners. Additionally, PyroGenesis offers a comprehensive suite of plasma arc systems for waste management, including: Onboard destruction of ship waste. Steam plasma cracking systems for breaking down refrigerants such as CFCs, HFCs, and HCFCs. Mobile platforms for the onsite neutralization of chemical warfare agents. Resource recovery systems for land-based waste processing and waste-to-energy applications. Specialized plasma torches for waste gasification and combustion, alongside general plasma arc gasification and vitrification solutions. The company also provides expert engineering, manufacturing services, and contract research, delivering complete turnkey process equipment packages to sectors spanning defense, metallurgy, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Their service offerings extend to installation, commissioning, and ongoing start-up support for their systems.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||